Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it has selected Nicky Bell as its second participant in the Future Directors programme.
Ms Bell is currently CEO of Saatchi & Saatchi, which she joined in 2010 after 10 years in New York as a Worldwide Managing Director at Ogilvy across many iconic brands. She is also a board member of the Communication Agencies Association of New Zealand, the Middlemore Foundation for Health Innovation, a member of the Global Women organisation and is an alumni of the Stanford University Graduate Business School.
This is the second appointment by the company under the Future Directors programme, following the very successful “Future Directorship” of Franceska Banga over the past year.
The Future Directors programme is run by the Institute of Directors and exposes talented executives with an interest in governance to a company board for a year. Founded in 2013 by Sir Stephen Tindall, Michael Stiassny (President, Institute of Directors) and Des Hunt (New Zealand Shareholders Association), the initiative is aimed at developing the next generation of New Zealand governance talent. Participants in the programme are assigned a mentor and attend board meetings where they participate in discussions, but are not involved in decision making.
Tony Carter, Chairman of Fisher & Paykel Healthcare said, “The Future Directors programme is an excellent initiative and we are committed to supporting up and coming directors. The company has benefited from the significant contribution Franceska has made over the past year and we are looking forward to Nicky contributing to our board discussions in 2016. We believe her experience with many global brands will be a real asset.”
Ms Bell is excited by the opportunity to contribute to the company and is looking forward to bringing her international experience to the board. Ms Bell said, “Participating in this programme with a board and company of the calibre of Fisher & Paykel Healthcare and within an industry that I’m passionate about is a fantastic opportunity. I’m very much looking forward to it.”
Ms Bell will take up her role with Fisher & Paykel Healthcare on 1 February 2016 for a 12 month term.
Fisher & Paykel Healthcare announces second Future Directors appointment
Delivering respiratory support for spontaneously breathing patients
Full face masks designed for comfort and care
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
Nasal High Flow and Humidification for patients at home and in long term care
Home respiratory therapies that deliver humidification via a mask or tracheotomy tube to support and complement the airway’s natural-defense mechanisms
A flow range of 2 to 60 L/min allows for use across the care continuum - from the most acute hospital environment to the home
With Optiflow you can independently titrate flow and FiO2 according to your patient's needs
F&P Evora™ incorporates CapFit headgear that has been designed to be put on like a cap
The adaptable, reliable and robust humidification system. Use with Evaqua™ 2 circuit technology to minimize condensate
Updates and support for healthcare professionals
Stories, news and media resources
Looking after our people, suppliers, communities and the environment